Comments
Loading...
Guidance e previsioni
GoodRx Holdings fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/06/2025 | GDRX | GoodRx Holdings | FY | 2025 | — | — | — | $792.30M | — | $819.72M | |
05/07/2025 | GDRX | GoodRx Holdings | FY | 2025 | — | — | — | $810.00M | $840.00M | $823.27M | |
05/07/2025 | GDRX | GoodRx Holdings | Q2 | 2025 | — | — | — | $203.00M | — | $206.30M | |
02/27/2025 | GDRX | GoodRx Holdings | FY | 2025 | — | — | — | $810.00M | $840.00M | $825.60M | |
02/27/2025 | GDRX | GoodRx Holdings | Q1 | 2025 | — | — | — | $201.00M | $205.00M | $202.58M | |
11/07/2024 | GDRX | GoodRx Holdings | FY | 2024 | — | — | — | $794.00M | $794.00M | $800.80M | |
11/07/2024 | GDRX | GoodRx Holdings | Q4 | 2024 | — | — | — | $200.00M | $200.00M | $206.25M | |
08/08/2024 | GDRX | GoodRx Holdings | FY | 2024 | — | — | — | $800.00M | $800.00M | $806.38M | |
08/08/2024 | GDRX | GoodRx Holdings | Q3 | 2024 | — | — | — | $193.00M | $197.00M | $202.37M | |
05/09/2024 | GDRX | GoodRx Holdings | Q2 | 2024 | — | — | — | $200.00M | $200.00M | $199.68M | |
05/09/2024 | GDRX | GoodRx Holdings | FY | 2024 | — | — | — | $800.00M | $810.00M | $800.99M | |
02/29/2024 | GDRX | GoodRx Holdings | Q1 | 2024 | — | — | — | $195.00M | $198.00M | $192.91M | |
02/29/2024 | GDRX | GoodRx Holdings | FY | 2024 | — | — | — | $800.00M | $800.00M | $790.53M | |
01/10/2024 | GDRX | GoodRx Holdings | Q4 | 2023 | — | — | — | $195.00M | $197.00M | $190.77M | |
01/10/2024 | GDRX | GoodRx Holdings | FY | 2023 | — | — | — | $759.00M | $761.00M | $744.26M | |
11/09/2023 | GDRX | GoodRx Holdings | FY | 2023 | — | — | — | $752.00M | $758.00M | $754.99M | |
11/09/2023 | GDRX | GoodRx Holdings | Q4 | 2023 | — | — | — | $188.00M | $194.00M | $192.67M | |
08/09/2023 | GDRX | GoodRx Holdings | FY | 2023 | — | — | — | $750.00M | $760.00M | $762.25M | |
08/09/2023 | GDRX | GoodRx Holdings | Q3 | 2023 | — | — | — | $186.00M | $190.00M | $192.58M | |
05/10/2023 | GDRX | GoodRx Holdings | FY | 2023 | — | — | — | $750.00M | $775.00M | $784.29M | |
05/10/2023 | GDRX | GoodRx Holdings | Q2 | 2023 | — | — | — | $185.00M | $188.00M | $191.68M | |
02/28/2023 | GDRX | GoodRx Holdings | FY | 2023 | — | — | — | $780.00M | $790.00M | $778.01M | |
02/28/2023 | GDRX | GoodRx Holdings | Q1 | 2023 | — | — | — | $181.00M | $183.00M | $181.72M | |
11/08/2022 | GDRX | GoodRx Holdings | Q4 | 2022 | — | — | — | $175.00M | $180.00M | $204.24M | |
08/08/2022 | GDRX | GoodRx Holdings | Q3 | 2022 | — | — | — | $185.00M | $185.00M | $201.40M | |
05/09/2022 | GDRX | GoodRx Holdings | Q2 | 2022 | — | — | — | $190.00M | $190.00M | $215.62M | |
02/28/2022 | GDRX | GoodRx Holdings | FY | 2022 | — | — | — | $916.87M | $916.87M | $1.02B | |
02/28/2022 | GDRX | GoodRx Holdings | Q1 | 2022 | — | — | — | $200.00M | $200.00M | $227.92M | |
11/10/2021 | GDRX | GoodRx Holdings | Q4 | 2021 | — | — | — | $212.00M | $222.00M | $216.92M | |
11/10/2021 | GDRX | GoodRx Holdings | FY | 2021 | — | — | — | $744.00M | $754.00M | $748.29M | |
08/12/2021 | GDRX | GoodRx Holdings | Q3 | 2021 | — | — | — | $193.00M | $197.00M | $195.15M | |
05/13/2021 | GDRX | GoodRx Holdings | FY | 2021 | — | — | — | $740.00M | $760.00M | $748.41M | |
05/13/2021 | GDRX | GoodRx Holdings | Q2 | 2021 | — | — | — | $172.00M | $176.00M | $172.44M | |
03/11/2021 | GDRX | GoodRx Holdings | Q1 | 2021 | — | — | — | $158.00M | $161.00M | $161.98M | |
03/11/2021 | GDRX | GoodRx Holdings | FY | 2021 | — | — | — | $735.00M | $755.00M | $737.62M |
FAQ
Qual è la guidance più recente per GoodRx Holdings (GDRX)?
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di GoodRx Holdings.
Sfoglia guidance e previsioni su tutte le azioni.